Shaping the future of cancer treatment with powerful therapeutic and diagnostic platforms

Key benefits of Affimer® technology

Learn more about pre|CISIONTM prodrugs

Therapeutics

Developing next generation cancer therapies.

Therapeutics

Diagnostics

Affimer® reagents are ideal tools for use in a wide variety of diagnostic applications.

Diagnostics
Investors

Significant long-term value, growing a pipeline of drug candidates

A proven platform technology able to address multiple markets, with significant potential as the Group builds a pipeline of valuable drug assets for development and licensing.

Download Avacta’s 2018 Annual Report and Accounts.

Download